Keros Therapeutics, Inc. (KROS)
10.50
-0.49
(-4.46%)
USD |
NASDAQ |
May 15, 16:00
10.51
+0.01
(+0.10%)
After-Hours: 20:00
Keros Therapeutics Shareholders Equity (Quarterly) : 285.63M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.505B |
| PTC Therapeutics, Inc. | -180.46M |
| Insmed, Inc. | 704.85M |
| United Therapeutics Corp. | 5.901B |
| Enanta Pharmaceuticals, Inc. | 116.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 312.29M |
| Total Liabilities (Quarterly) | 26.66M |
| Debt to Equity Ratio | 0.0571 |
| Current Ratio | 22.62 |
| Net Debt Paydown Yield | 0.23% |